Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 4/20 | 0.65 |
| ▸ | GCGR | P47871 | 1/20 | 0.65 |
| ▸ | GIPR | P48546 | 1/20 | 0.65 |
| ▸ | IL23R | Q5VWK5 | 11/20 | 0.63 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.60 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.60 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30299227 | 0.93 | GLP1R (0.68) | GLP1RGCGRGIPRIL23RNR3C1 | |
| SCHEMBL29638070 | 0.90 | GLP1R (0.65) | GLP1RGCGRGIPRNR3C1ECE1 | |
| SCHEMBL29540171 | 0.90 | IL23R (0.64) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL30906400 | 0.90 | GLP1R (0.69) | GLP1RGCGRGIPRNR3C1ECE1 | |
| SCHEMBL31683332 | 0.90 | NR3C1 (0.69) | GLP1RGCGRGIPRIL23RNR3C1 | |
| SCHEMBL31665973 | 0.90 | GLP1R (0.65) | GLP1RGCGRGIPRIL23RNR3C1 | |
| SCHEMBL34467247 | 0.89 | IL23R (0.64) | IL23RKISS1R | |
| SCHEMBL29540457 | 0.89 | GLP1R (0.63) | GLP1RGCGRGIPRIL23RNR3C1 | |
| SCHEMBL30607349 | 0.89 | NR3C1 (0.69) | GLP1RGCGRGIPRNR3C1ECE1 | |
| SCHEMBL11420342 | 0.89 | IL23R (0.66) | IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230065816-A1 | METHODS FOR PREVENTING AND REVERSING OPIOID ANALGESIC TOLERANCE IN SUBJECTS WITH CHRONIC PAIN | THE REASEARCH FOUND FOR SUNY (US) | 2023-03-02 | — | — | US | disclosed |